We use cookies for statistical purposes as part of our work to create a good website.
Unless you say "no thanks to cookies", we assume that you agree to our cookie policy.

You can also click yes to cookies to accept our cookie policy.

A leading life science hub

Medicon Valley - The innovative heart of Scandinavian life science

Welcome to Medicon Valley - the life science cluster of Greater Copenhagen and the crucible of Scandinavian life sciences. Located at the gateway to Denmark and Sweden it has a vibrant ecosystem and deep talent pool underpinned by world-class life science universities and research infrastructure.

Set in a competitive business environment with the Scandinavian quality of life close at hand, Medicon Valley is an attractive location for both business and people.

Scandinavian innovation is globally recognized and our life sciences reflect this. Within Medicon Valley we have a rich life science heritage and pioneering spirit that continues to attract many successful companies. Companies like Novo Nordisk, LEO Pharma, Baxter Gambro and Lundbeck are representative, but so too are the many smaller innovative start-ups who continue to energise the area.

Medicon Valley in numbers:

  • 40,000 people employed in life sciences
  • 90% of Scandinavian life science graduates
  • 4 world leading life science universities
  • 6,000 PhD students
  • 350 biotech, medtech & pharma companies with local R&D

Northern Europe's hub for science and innovation

The Medicon Valley ecosystem and research infrastructure provides you with an exceptional environment in which to invest or locate your business.

You will have access to one of Europe’s leading life science clusters with state-of-the-art research infrastructure including world-class life science universities, hospitals and science parks. With a deep talent pool of 40,000 high quality people working in the life science sector, 14,000 researchers and 6,000 PhD students in science, engineering and medicine you have an exceptional quality of talent to draw upon.

In terms of the future,  Medicon Valley will become a world leading research hub for materials science and life sciences, with the opening of MAX IV in 2016, and the European Spallation Source ERIC in 2019. This will further enhance the innovative reputation and opportunities for the Medicon Valley cluster.